Vaccines

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - The Canadian Immunization Conference (CIC)

Short-term Thinking about Influenza Underestimates the True Disease Burden in Older Patients

Ottawa, Ontario / December 6-8, 2016

Ottawa - Short-term thinking about influenza infection limits the illness to the acute period of illness when in fact, functional decline following hospitalization for influenza can be persistent and life-altering. Among the well, vaccine...

PRIORITY PRESS - 28th International Congress of Pediatrics (IPA 2016)

Primary Care Primer on Seasonal Influenza Vaccination and Why it Matters in Children

Vancouver, BC / August 17-22, 2016

Vancouver - Uptake of the seasonal influenza vaccine is far from optimal in pediatric practice and physicians have an important role to play in helping parents understand why influenza vaccination is critical for infants and young children....

MEDI-NEWS - Based on CATMAT - An Advisory Committee Statement (ACS)

Prevention of Travellers’ Diarrhea: Strategies To Reduce the Risk

November 2015

Travellers’ diarrhea affects approximately half of those who travel to low- and middle-income countries. While often self-limiting, up to half of travellers who acquire travellers’ diarrhea will be inconvenienced by the...

PRIORITY PRESS - 13th Annual Primary Care Today

Primer on the Prevention of Invasive Meningococcal Disease: Perspectives from Pediatric Practices

Toronto, Ontario / May 6-9, 2015

Toronto - Invasive meningococcal disease (IMD) is a rare but catastrophic disease associated with high morbidity and mortality rates. Today by far and away the greatest proportion of IMD in Canada is caused by Neisseria meningitidis...

PRIORITY PRESS - 13th Annual Primary Care Today

Update on the 9-valent HPV Vaccine: Taking Prevention to a New Level

Toronto, Ontario / May 6-9, 2015

Toronto - A new 9-valent vaccine against the human papilloma virus (HPV) has recently been approved by Health Canada and is indicated for use in young girls and women between 9 and 45 years of age as well as in boys and men between 9 and 26...

PRIORITY PRESS - 11th Canadian Immunization Conference

Influenza in the Elderly: Seeking More Effective Vaccine Strategies

Ottawa, Ontario / December 2-4, 2014

Ottawa - Elderly patients are at high risk for developing influenza and its complications, which can include increased frailty after hospitalization. Immunization in this population is vital, despite the fact that immune senescence lowers...

PRIORITY PRESS - 11th Canadian Immunization Conference

Expanding Protection against Influenza in the Most Vulnerable: Focus on Adjuvanted Influenza Vaccines

Ottawa, Ontario / December 2-4, 2014

Ottawa – The burden of illness associated with influenza infection is considerable, and it is particularly pronounced in the very young and in the elderly. Both groups respond less than optimally to standard influenza vaccines and...

PRIORITY PRESS - 11th Canadian Immunization Conference

Integrating the New Meningococcal B Vaccine into Clinical Practice: Lessons From the Experts

Ottawa, Ontario / December 2-4, 2014

Ottawa – Of the 5 serogroups responsible for invasive meningococcal disease (IMD), serogroup B is by far the most common in Canada today.  IMD also disproportionately affects young infants with another peak in incidence in...

PRIORITY PRESS - 11th Canadian Immunization Conference

A Primer on HPV Vaccination for Primary Care Practitioners: NACI Recommendations Should Prevail

Ottawa, Ontario / December 2-4, 2014

Ottawa - Primary care providers are required to answer three questions for patients when they come asking about the human papilloma virus (HPV) vaccine: Is it safe? Does it work? And what do you think about it? Providing good,...

MEDI-NEWS - Based on an interim safety surveillance report by L'Institut national de santé publique du Québec (INSPQ) (Funded by the Quebec Ministry of Health and Social Services) Original report in French at http://www.inspq.qc.ca/pdf/publications/1885_Vaccin_Menincogoque_SerogroupeB.pdf

Interim Surveillance Report on the Safety of a Large-Scale Vaccination Campaign Against Serogroup B Neisseria meningitidis

September 2014

Quebec City - Invasive meningococcal disease (IMD) caused by serogroup B Neisseria meningitidis is the most common IMD in Canada today. The incidence of serogroup B disease is also highest in infants under the age of 12 months, children...

PAGE 1 OF 12   1 2 3 4 5 6 7 8 9 10 ...